Evidence map›Paper›PMID 29296132›Full record

ArticleCanadian geriatrics journal : CGJ2017

Proceedings of the Canadian Frailty Network Summit: Medication Optimization for Frail Older Canadians, Toronto, Monday April 24, 2017.

John Muscedere, Perry Kim, Peter Aitken, Michael Gaucher, Robin Osborn, Barbara Farrell, Jayna Holroyd-Leduc, Laurie Mallery, Henry Siu, James Downar and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Canadian geriatrics journal : CGJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Winter Issue, 2017.Canadian geriatrics journal : CGJ · 2017
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 2 countries.

John MuscedereDepartment of Critical Care Medicine, Queen's University, Kingston, ON, Canada.
Perry KimCanadian Frailty Network, Kingston, ON, Canada.
Peter AitkenPartnerships, Development and Government Relations, Canadian Frailty Network, Kingston, ON, Canada.
Michael GaucherPharmaceuticals and Health Workforce Information Services, Canadian Institute of Health Information, Ottawa, ON, Canada.
Robin OsbornInternational Health Policy and Practice Innovations for the Commonwealth Fund, New York, NY, U.S.A.
Barbara FarrellBruyère Research Institute, Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada.
Jayna Holroyd-LeducMedicine and Community Health Science, University of Calgary, Calgary, AB, Canada.
Laurie MalleryGeriatric Medicine, Dalhousie University, Halifax, NS, Canada.
Henry SiuFamily Medicine at McMaster University, Hamilton, ON, Canada.
James DownarDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Todd C LeeMcGill University Health Centre, Montreal, HQ, Canada.
Emily McDonaldMcGill University Health Centre, Montreal, HQ, Canada.
Lisa BurryMount Sinai Hospital, Toronto, ON, Canada.
McGill University Health Centre · CAUniversity of Toronto · CACanadian Institute for Health Information · CACommonwealth Fund · USDalhousie University · CAMcMaster University · CAQueen's University · CAUniversity of Calgary · CAUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Appropriate and optimal use of medication and polypharmacy are especially relevant to the care of older Canadians living with frailty, often impacting their health outcomes and quality of life. A majority (two thirds) of older adults (65 or older) are prescribed five or more drug classes and over one-quarter are prescribed 10 or more drugs. The risk of adverse drug-induced events is even greater for those aged 85 or older where 40% are estimated to take drugs from 10 or more drug classes. The Canadian Frailty Network (CFN), a pan-Canadian non-for-profit organization funded by the Government of Canada through the Networks of Centres of Excellence Program (NCE), is dedicated to improving the care of older Canadian living with frailty and, as part of its mandate, convened a meeting of stakeholders from across Canada to seek their perspectives on appropriate medication prescription. The CFN Medication Optimization Summit identified priorities to help inform the design of future research and knowledge mobilization efforts to facilitate optimal medication prescribing in older adults living with frailty. The priorities were developed and selected through a modified Delphi process commencing before and concluding during the summit. Herein we describe the overall approach/process to the summit, a summary of all the presentations and discussions, and the top ten priorities selected by the participants.

Indexed as

deprescribingfrailtymedication optimizationolder adultspolypharmacyseniors

Identifiers

PMID29296132
PMCPMC5740949
OpenAlexW2777955464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.